Dicyclomine

Bentyl (dicyclomine) is a small molecule pharmaceutical. Dicyclomine was first approved as Bentyl on 1984-10-15. It is used to treat irritable bowel syndrome in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M3 and muscarinic acetylcholine receptor M1. In addition, it is known to target muscarinic acetylcholine receptor M2 and muscarinic acetylcholine receptor M4.